A Survey of Patient Understanding of Muscle
Invasive Bladder Cancer Treatment

Now Enrolling, Learn How You Can Refer Patients

CONTACT EVIDERA:  [email protected]

A survey will be used evaluate patient perspectives of MIBC and treatment options, risk of recurrence, fear of cancer recurrence, and impacts on health-related quality of life. Eligible patients will be expected to complete a one-time 20-minute web-based survey about their perspectives of MIBC. Patients will be reimbursed for their time. This study does not involve treatment and will not interfere with usual care.

We would like to partner with urology practices that are able to recruit and enroll a minimum of 25 eligible patients over a 3-month time window.

Basic criteria for patient eligibility:

• Individuals ≥18 years
• Stage II, Stage IIIA, or Stage IIIB MIBC
• Plan to have radical cystectomy (RC) within six months OR underwent RC within past year
  
  

Refer Patients

• Your patients will be provided the opportunity to use their voice in research. This study will evaluate patient knowledge of treatment options, risk of recurrence, fear of cancer recurrence, impacts on decision making, and impacted on health-related quality of life.
• Patients in this study will receive compensation for completing the web-based survey.
• CONTACT EVIDERA:  [email protected]
  
  

About the Study

PROTOCOL TITLE: Early-stage renal cell carcinoma and muscle invasive bladder cancer patients’ perception of risk and fear for recurrence, barriers, and facilitators for seeking adjuvant treatment

INDICATION: Muscle-Invasive Bladder Cancer (MIBC)

STUDY DRUG: None

STUDY DESIGN: Non-interventional, observational web-based survey

STUDY POPULATION: Number of patients to be clinically recruited: up to 80

STUDY DURATION: Participant involvement will include being screened and completing an electronic survey

STUDY OBJECTIVES:  

Primary Objectives

• Assess patient knowledge of MIBC treatment options (neoadjuvant/adjuvant therapies)
• Assess patient understanding and knowledge of the concepts of disease-free survival (DFS) and event-free survival (EFS)
• Assess patient perception of risk of recurrence
• Assess patient FCR

Exploratory Objectives

• Identify patient socioeconomic or cultural factors that may impact perioperative decision making
• Assess the impact of patient FCR on HRQoL-related constructs, such as fear, anxiety, and depression
• Identify barriers and facilitators in patients’ decision to choose neoadjuvant and/or adjuvant treatment